As these target genes regulate epigenetic processes on a global scale during embryonic development, it is likely that the developmental defects observed in patients affected by FBRSL1-associated syndrome are in part caused by a dysregulation of their expression. This evidence concerns the gene FBRSL1 and Down syndrome.